59th Annual Meeting of the Japanese Society of Neurology

Sessions

Wed. May 23, 2018

99 results  (31 - 40)

  • Luncheon Seminar

[LS-01] Medical Division, Novartis Pharma K.K.

It is time to think about the benefit-risk balance of fingolimod from the perspectives in case reports

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 5 (Sapporo Geibunkan / Seiryu (3F))

Chair: Takashi Yamamura(Director and Chief of the Neuroimmunology Section, Director of Multiple Sclerosis Center, the Department of Immunology, National Institute of Neuroscience,
National Center of Neurology and Psychiatry)

  • Luncheon Seminar

[LS-02] Japan Blood Products Organization

maintenance treatment and IVIg therapy in CIDP

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 6 (Sapporo Geibunkan / Gyokuyou (3F))

Chair: Satoshi Kuwabara(Professor, Department of Neurology, Graduate School of Medicine, Chiba University)

  • Luncheon Seminar

[LS-03] Alexion Pharma GK

See the possibility for generalized myasthenia gravis patients -What Soliris can do?-

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 8 (Royton Sapporo / Empress Hall (2F))

Chair: Masakatsu Motomura(Professor, Doctor of Medicine Medical Engineering Course Department of Engineering, The Faculty of Engineering, Nagasaki Institute of Applied Science (NiAS))

  • Luncheon Seminar

[LS-04] Eisai Co., Ltd.

Treatment strategies for Alzheimer's disease

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 9 (Royton Sapporo / Regent Hall (2F))

Chair: Hitoshi Okazawa(Professor & Chair, Department of Neuropathology / Director, Center for Brain Integration Research, Tokyo Medical and Dental University)

  • Luncheon Seminar

[LS-05] Biogen Japan Ltd. / Eisai Co., Ltd.

Therapeutic options considering the long-term prognosis of MS

Wed. May 23, 2018 12:05 PM - 1:05 PM Room 10 (Royton Sapporo / Highness Hall (2F))

Chair: Toshiyuki Fukazawa(Sapporo Neurology Hospital)